Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01726556
Other study ID # 1Trg-PG-2012/5054
Secondary ID
Status Completed
Phase N/A
First received November 7, 2012
Last updated January 9, 2013
Start date April 2011
Est. completion date December 2012

Study information

Verified date January 2013
Source Postgraduate Institute of Medical Education and Research
Contact n/a
Is FDA regulated No
Health authority India: Dept of Pulmonary Medicine, PIMER, Chandigarh
Study type Interventional

Clinical Trial Summary

Rigid thoracoscopy is an established procedure for the performance of pleural biopsies for undiagnosed pleural effusions. The semirigid thoracoscope is a relatively new instrument designed for the same purpose which is claimed to be more user-friendly. The two devices have not been compared in a head-to-head trial in published literature. The investigators attempt to conduct a randomised comparative trial between the two devices.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group 12 Years and older
Eligibility Inclusion Criteria:

- Patients with an exudative (as defined by Light's criteria) pleural effusion of unknown etiology after a microbiological (namely gram stain and acid fast bacillus stain) and cytological examination

Exclusion Criteria:

- Significant hypoxemia on room air

- Hemodynamic instability

- Significant cardiac disease (known myocardial infarction in last 6 weeks or presence of unstable angina)

- Refractory cough

- Lack of pleural space due to adhesions

- Uncorrected coagulopathy

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
Rigid thoracoscope (Richard Wolf GmbH, Knittlingen, Germany)
Pleuroscopy using a rigid thoracoscope manufactured by Richard Wolf GmbH, Knittlingen, Germany
Semirigid thoracoscope (model LTF-160Y1, Olympus, Japan)
Pleuroscopy using a semirigid thoracoscope model LTF-160Y1, manufactured by Olympus Medical Systems Corporation, Tokyo, Japan

Locations

Country Name City State
India Postgraduate Institute of Medical Education and Research Chandigarh

Sponsors (1)

Lead Sponsor Collaborator
Postgraduate Institute of Medical Education and Research

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Other Use of sedation and analgesia during the procedure The quantity of drugs used for sedation and analgesia during the procedure would be recorded and compared between the two arms At the end of procedure No
Other Operators' experience characteristics These would include, on a numerical scale of 0 to 100, the operator's grading of the following characteristics: quality of thoracoscopic image, ease of maneuvering, ease of taking a biopsy and the operator's expectation that the biopsy will reveal a definitive histological diagnosis At the end of the procedure No
Primary Diagnostic yield of thoracoscopic biopsy by intention to treat analysis The proportion of patients where thoracoscopic pleural biopsy yielded a diagnosis that was consistent with the present clinical picture and the further follow-up of the patients, would be calculated and compared between the two arms 3 months No
Secondary Yield of biopsies successfully completed The diagnostic yield of only those procedures would be considered separately where a biopsy could be successfully done and compared between the two arms 3 months No
Secondary Complications Number of major and minor complications encountered in the two arms 3 months Yes
Secondary Scar size Scar size (in mm) in the longest axis At the end of the procedure No
Secondary Biopsy size Biopsy size (in mm) in the longest axis At the end of the procedure No